Overview
Gecilmara Pileggi practices in Sao Paulo, Brazil. Pileggi is rated as a Distinguished expert by MediFind in the treatment of COVID-19. Their top areas of expertise are COVID-19, Rubella, Togaviridae Disease, and Yellow Fever.
Their clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 19 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- COVID-19Pileggi isDistinguished. Learn about COVID-19.
- Advanced
- RubellaPileggi isAdvanced. Learn about Rubella.
- Togaviridae DiseasePileggi isAdvanced. Learn about Togaviridae Disease.
- Yellow FeverPileggi isAdvanced. Learn about Yellow Fever.
- Experienced
- Acute PainPileggi isExperienced. Learn about Acute Pain.
- ArthritisPileggi isExperienced. Learn about Arthritis.
- ChickenpoxPileggi isExperienced. Learn about Chickenpox.
- ChikungunyaPileggi isExperienced. Learn about Chikungunya.
- Cutaneous Lupus Erythematosus (CLE)
- Dry Eye SyndromePileggi isExperienced. Learn about Dry Eye Syndrome.